TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
OPT

Opthea Ltd

Healthcare · Biotechnology

3.40$ +7.2% vs. previous close Closing price · As of: Jul 2, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios OPT
Line item Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q1 25
Margins
-336.7% 13.3% -35.6% 2.8% 17.7% 1.3%
-165,128.6% -63,018.0% -91,505.0% -71,935.5% -74,210.8% -106,470.4%
-158,654.5% -60,866.9% -88,908.5% -69,322.0% -70,435.6% -103,347.1%
-129,102.4% -48,925.4% -75,441.6% -58,743.8% -59,465.3% -81,826.0%
Returns
-64.4% -75.2% -199.0% -377.8% -258.8% -350.7%
-63.0% -69.0% -159.0% -301.9% -94.9% -128.6% -206.1% -216.7% -245.2%
Balance Sheet & Debt
-118 -121 -209 -134 -157 -31 -132
97.7% 91.8% 79.9% 79.9% 36.7% 36.7% -5.9% -5.9% -28.2% -40.2% -115.7%
0.0 0.0 0.0
Per Share
-0.24 -2.23 -0.36 -4.12 -0.49 -4.72 -0.73 -5.18 -5.51
0.00 -0.01 0.00 0.00 0.00 0.01 0.00 0.01 0.01
0.38 2.96 0.18 1.09 0.19 1.34 -0.02 -0.14 -0.63 -0.89 -2.11
-0.27 -2.39 -0.35 -3.35 -0.39 -4.00 -0.62 -4.38 -4.36

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?